These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39060688)

  • 1. Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency.
    Masoud SJ; Saxton AT; Lidsky ME; Martin AN; Herbert GS; Blazer DG; Allen PJ; Cerullo M
    Ann Surg Oncol; 2024 Nov; 31(12):8287-8297. PubMed ID: 39060688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate.
    Brant A; Lewicki P; Rhodes S; Arenas-Gallo C; Strasser MO; Zhu A; Ponsky L; Shoag JE
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):252-256. PubMed ID: 36717642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
    Horný M; Shafer PR; Dusetzina SB
    JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hospital price transparency after implementation of the CMS Final Rule.
    Brant A; Lewicki P; Rhodes S; Zhu A; Shoag J
    Health Serv Res; 2024 Aug; 59(4):e14329. PubMed ID: 38804181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures.
    Zhang Y; Cerullo M; Esposito A; Golla V
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1215-1222.e1. PubMed ID: 36351331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
    Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
    JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drivers of Medicare Reimbursement for Thoracolumbar Fusion: An Analysis of Data From The Centers For Medicare and Medicaid Services.
    Khanna K; Padegimas EM; Zmistowski B; Howley M; Verma K
    Spine (Phila Pa 1976); 2017 Nov; 42(21):1648-1656. PubMed ID: 28338572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
    Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
    JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hospital Monopoly Status, Patient Socioeconomic Disadvantage, and Total Joint Arthroplasty Price Disclosure.
    Peairs EM; Zhang GX; Kerr D; Erickson MM; Zhang Y; Cerullo M
    J Am Acad Orthop Surg; 2023 Oct; 31(19):1019-1026. PubMed ID: 37205874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
    Jiang JX; Polsky D; Littlejohn J; Wang Y; Zare H; Bai G
    J Gen Intern Med; 2022 Nov; 37(14):3577-3584. PubMed ID: 34902095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Surgeon and Patient Estimated Cost and Reimbursement for Common General Surgical Operations and Benefit of Centers for Medicare and Medicaid Services Price Transparency Rules.
    Frazier GD; Turrentine FE; Williams MD
    J Am Coll Surg; 2023 May; 236(5):1003-1010. PubMed ID: 36622650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Reimbursement for Total Joint Arthroplasty: The Driving Forces.
    Padegimas EM; Verma K; Zmistowski B; Rothman RH; Purtill JJ; Howley M
    J Bone Joint Surg Am; 2016 Jun; 98(12):1007-13. PubMed ID: 27307361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Medicare reimbursement for neurosurgical procedures: 2000 to 2018.
    Haglin JM; Richter KR; Patel NP
    J Neurosurg; 2020 Feb; 132(2):649-655. PubMed ID: 30717049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.
    Nikpay S; Carroll C; Golberstein E; Abraham JM
    J Healthc Manag; 2024 Jan-Feb 01; 69(1):45-58. PubMed ID: 38175534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations.
    Shah SA; Zhang Y; Correa AM; Hijaz BA; Yang AZ; Fayanju OM; Cerullo M
    Breast Cancer Res Treat; 2024 Jan; 203(2):397-406. PubMed ID: 37851289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedure Reimbursement, Inflation, and the Declining Buying Power of the Vascular Surgeon (2011-2021).
    Haglin JM; Edmonds VS; Money SR; Davila VJ; Stone WM; Soh IY; Meltzer AJ
    Ann Vasc Surg; 2021 Oct; 76():80-86. PubMed ID: 33901616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial viability of endovascular aortic repair in the modern era.
    Brinster CJ; Escousse GT; Bazan HA; Leithead CC; Sternbergh WC
    J Vasc Surg; 2021 Feb; 73(2):494-501. PubMed ID: 32473346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
    Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
    Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Characteristics Associated With Penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program.
    Rajaram R; Chung JW; Kinnier CV; Barnard C; Mohanty S; Pavey ES; McHugh MC; Bilimoria KY
    JAMA; 2015 Jul; 314(4):375-83. PubMed ID: 26219055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
    Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD
    J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.